Hims & Hers Health, Inc. (HIMS)
33.72
-0.38
(-1.11%)
USD |
NYSE |
Dec 30, 13:46
Hims & Hers Health Research and Development Expense (Quarterly): 40.58M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Pfizer Inc. | 2.492B |
| Boston Scientific Corp. | 514.00M |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Recursion Pharmaceuticals, Inc. | 107.66M |